Showing results (501-510 of 608) with videos related to
Sort By:
Pageof 61
Neuroscience and Biobehavioral Reviews|August 28, 2024
Real-time fMRI-based neurofeedback to restore brain function in substance use disorders: A systematic review of the literatureEthan Murphy, Govinda Poudel, Saampras Ganesan, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 1, 1997
A molecular, clinical, and immunohistochemical study of vestibular schwannomaR M Irving, D A Moffat, D G Hardy, et al.Advanced Healthcare Materials|January 9, 2013
Mesoporous europo-gadolinosilicate nanoparticles as bimodal medical imaging agents and a potential theranostic platformNicholas M K Tse, Danielle F Kennedy, Nigel Kirby, et al.Geburtshilfe Und Frauenheilkunde|June 1, 1976
[Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)]P Börner, H Deicher, I Bähr, et al.Clinical Endocrinology|March 1, 1980
Immunoreactive somatostatin changes during insulin-induced hypoglycaemia and operative stress in manJ A Wass, E Penman, S Medbak, et al.Journal of Clinical Pharmacology|August 1, 1981
Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implicationsM Levitt, A Wilson, D Bowman, et al.Deutsche Medizinische Wochenschrift (1946)|May 20, 1977
[Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)]P Börner, H Deicher, I Bähr, et al.Cancer Research|April 19, 2007
An imaging biomarker of early treatment response in prostate cancer that has metastasized to the boneKuei C Lee, Sudha Sud, Charles R Meyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4Weilian Yang, Rolf F Barth, Gong Wu, et al.Gene Therapy|September 16, 2005
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefitK C Lee, D A Hamstra, S Bullarayasamudram, et al.Pageof 61